Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-017332

NovoCure Ltd · NVCR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Wilhelmus Cm Groenhuysen
Officer — Chief Financial Officer
Period of report
Mar 4, 2019
Accepted (ET)
Mar 6, 2019 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1Mar 4, 2019M18,766$3.44A85,030D
Ordinary SharesF2Mar 4, 2019S5,396$53.906D79,634D
Ordinary SharesF3Mar 4, 2019S3,400$54.558D76,234D
Ordinary SharesF4Mar 4, 2019S4,748$56.035D71,486D
Ordinary SharesF5Mar 4, 2019S5,222$56.521D66,264D
Ordinary SharesF1Mar 4, 2019M40,000$3.44A106,264D
Ordinary SharesF6Mar 4, 2019S25,851$52.903D80,413D
Ordinary SharesF7Mar 4, 2019S4,207$53.816D76,206D
Ordinary SharesF8Mar 4, 2019S2,800$54.543D73,406D
Ordinary SharesF9Mar 4, 2019S2,800$55.948D70,606D
Ordinary SharesF10Mar 4, 2019S4,342$56.503D66,264D
Ordinary SharesF1Mar 5, 2019M31,234$3.44A97,498D
Ordinary SharesF11Mar 5, 2019S31,234$53.404D66,264D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Options to Buy Ordinary SharesF12$3.44Mar 4, 2019M18,766D—Dec 13, 2021Ordinary Shares18,766315,897D
Options to Buy Ordinary SharesF12$3.44Mar 4, 2019M40,000D—Dec 13, 2021Ordinary Shares40,000275,897D
Options to Buy Ordinary SharesF12$3.44Mar 5, 2019M31,234D—Dec 13, 2021Ordinary Shares31,234244,663D

Explanation of responses